Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.60
-0.27 (-2.27%)
May 21, 2026, 11:00 AM EDT - Market open
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Phathom Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $23.7. The average 1-year stock price forecast is 104.31% higher than the current stock price, while the lowest is $13 (+12.07%) and the highest is $29 (+150.00%).
Price Target: $23.7 (+104.31%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 27, 2026.
Analyst Ratings
The average analyst rating for Phathom Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Buy Upgrades $16 → $18 | Hold → Buy | Upgrades | $16 → $18 | +55.17% | Mar 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $20 → $25 | Strong Buy | Maintains | $20 → $25 | +115.52% | Feb 27, 2026 |
| Barclays | Barclays | Hold Initiates $16 | Hold | Initiates | $16 | +37.93% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $26 | Strong Buy | Maintains | $20 → $26 | +124.14% | Oct 31, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +46.55% | Jun 9, 2025 |
Financial Forecast
Revenue This Year
338.92M
from 175.11M
Increased by 93.55%
Revenue Next Year
547.02M
from 338.92M
Increased by 61.40%
EPS This Year
-0.68
from -3.03
EPS Next Year
1.17
from -0.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 355.0M | 685.9M | ||||||
| Avg | 338.9M | 547.0M | ||||||
| Low | 319.0M | 488.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 102.7% | 102.4% | ||||||
| Avg | 93.5% | 61.4% | ||||||
| Low | 82.2% | 44.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.30 | 1.69 | ||||||
| Avg | -0.68 | 1.17 | ||||||
| Low | -1.06 | 0.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.